Contracts › 75A50125C00018
75A50125C00018: The Scope of Work for This Contract Includes the Following Development Essentials: Cmc Development, Pre-Clinical and Clinical Studies, Device Development Activities, Human Factors Testing, Market Viability Assessments Along With All Associated Regula
Awarded to Rafa Laboratories Ltd by Office of Assistant Secretary for Preparedness and Response.
$12.0Mobligated
$147.7Mpotential value
31 December 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50125C00018 |
|---|---|
| Awardee | Rafa Laboratories Ltd |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN44 Health R&D Services; Health Care - Other; R&D Administrative Expenses |
| Offers received | 1 |
| Period of performance | 29 September 2025 to 31 December 2028 |
| Potential end | 30 June 2036 |
| Estimated recompete solicitation | ~Q3 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record